Astex Pharmaceuticals, Inc. (ASTX)
-NasdaqGS 5.87 
0.14(2.25%) 4:00PM EDT|After Hours
:
5.87 0.00 (0.00%) 4:26PM EDT - Nasdaq Real Time Price
| Prev Close: | 6.01 |
|---|
| Open: | 6.00 |
|---|
| Bid: | 5.77 x 800 |
|---|
| Ask: | 5.85 x 200 |
|---|
| 1y Target Est: | 7.33 |
|---|
| Beta: | 1.65 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 5.78 - 6.22 |
|---|
| 52wk Range: | 1.57 - 6.95 |
|---|
| Volume: | 1,998,832 |
|---|
| Avg Vol (3m): | 1,571,370 |
|---|
| Market Cap: | 549.89M |
|---|
| P/E (ttm): | 122.29 |
|---|
| EPS (ttm): | 0.05 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Astex Pharmaceuticals Inc Stock Downgraded (ASTX)at TheStreet(Wed, May 1)
- Expert Analyst Ian Somaiya Discusses the Decline in European Drug Pricing with The Wall Street Transcript; Models a 1% to 2% Annual Decline in Price for Companies That Sell OverseasWall Street Transcript(Tue, Apr 30)
- Astex Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Mon, Apr 29)
- BRIEF-Astex Pharmaceuticals shares up 1 pct after the bell following resultsat Reuters(Mon, Apr 29)
- Astex Pharmaceuticals Reports 2013 First Quarter Financial ResultsGlobeNewswire(Mon, Apr 29)
- ASTEX PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online(Mon, Apr 29)
- Q1 2013 Astex Pharmaceuticals Inc Earnings Release - After Market CloseCCBN(Mon, Apr 29)
- 5 Reasons to Worry About Next Weekat Motley Fool(Fri, Apr 26)
- Astex Pharmaceuticals to Present at Needham Healthcare ConferenceGlobeNewswire(Tue, Apr 23)
- Astex Pharmaceuticals to Announce 2013 First Quarter Financial Results on April 29thGlobeNewswire(Mon, Apr 22)
- Biotech Stocks Get A Turbo Boost From Vertexat Seeking Alpha(Sat, Apr 20)
- Early-Stage Clinical Data Highlights From AACR 2013at Seeking Alpha(Wed, Apr 17)
- This Week in Biotechat Motley Fool(Sat, Apr 13)
- 3 Humongous Health-Care Stocks This Weekat Motley Fool(Fri, Apr 12)
- Trader bets Astex will hold current leveloptionMONSTER(Fri, Apr 12)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 6.76 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.37 |
|---|
| Quarterly EPS Est
(Mar-13)
: | -0.06 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Astex Pharmaceuticals, Inc. engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology using its fragment-based drug discovery platform, Pyramid.
View More